Throughout history, humanity has faced numerous failures in the development of new drugs.

The development of technology to reduce such failure rates is crucial for the health and happiness of humanity.

Our company's goal is to establish an innovative in-vitro platform that helps to uncover useful new drug candidates at an earlier stage and dramatically reduce animal testing.

To achieve this, we are developing organ-on-a-chip technology, which recreates the major microstructures of human organs such as the heart, brain, and liver.

We aspire to make this new platform, such as organ-on-a-chip, groundbreaking technology that significantly increases the success rate of new drug development for humanity.
We are committed to giving our utmost effort, and we ask for your attention and encouragement.